Universal CAR-T Cells Targeting Multiple Myeloma

Clinical trial NCT06006741 · RECRUITING

Trial details

NCT number: NCT06006741
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Remission

Start date: 2023-10-31
Primary completion: 2026-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.